Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.
about
Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.FXR and liver carcinogenesisSRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.FXR induces SOCS3 and suppresses hepatocellular carcinoma.Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway.Defining the relationship between farsenoid X receptor, hepatitis B virus X protein and hepatocellular carcinoma: It's complicated.Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites.Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.Update on FXR Biology: Promising Therapeutic Target?FXR, intestinal FiXeR of hepatocellular carcinoma?Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivationNuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?
P2860
Q33687018-A2097B05-93DD-4A4E-A434-EC09D9F0134CQ36063712-06296C4A-23D1-410E-B890-E78E8BE698D8Q36300613-D89D788E-2933-4F8E-8B4C-0B2A48D8C469Q36544161-0FCE2BDB-83C5-4916-91B8-D427552D634BQ36638394-861BE045-3628-4CDB-9102-D30909A88DBFQ37139504-47BEA196-FEA8-4ADB-BC2B-6075107B1E13Q37571940-EA08FC0C-0035-4431-801F-6F5531737855Q40365783-5C9FE2B8-7D3E-415D-A8C6-713BFF5E9AB0Q42053662-30EE1AF9-D759-48BF-BBF2-268575AFBFC3Q45331943-BCC1F7E2-6FAC-4710-9A32-43A1E8F378E9Q46309148-A424DCC3-7864-4756-96BE-A8F3C7587D64Q47217714-712BC109-D3FD-4DA0-B07A-9FEB8C621BE6Q47668921-5BBF768B-9F39-40F5-BA9B-EFAFD55514EBQ49569061-3CF589B7-EEC3-444C-8E44-71D50AB9A36BQ52582202-127AA117-2850-4484-93BA-74AD998C6CD2Q57114776-1BA23FB2-35B9-4B29-8A94-3CF7EE3E154CQ57147758-C3B42BE3-94F7-4163-AF7D-F6CC61527827Q57147768-168E179F-C004-40BA-9863-8C4F9E88E17BQ57149637-F79925CB-EEA7-4702-81D4-49953C84099D
P2860
Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Small heterodimer partner over ...... soid X receptor knockout mice.
@ast
Small heterodimer partner over ...... soid X receptor knockout mice.
@en
type
label
Small heterodimer partner over ...... soid X receptor knockout mice.
@ast
Small heterodimer partner over ...... soid X receptor knockout mice.
@en
prefLabel
Small heterodimer partner over ...... soid X receptor knockout mice.
@ast
Small heterodimer partner over ...... soid X receptor knockout mice.
@en
P2093
P2860
P1476
Small heterodimer partner over ...... esoid X receptor knockout mice
@en
P2093
Grace L Guo
Guodong Li
James P Luyendyk
Jessica A Williams
Karen M Kassel
Ossama Tawfik
P2860
P304
P356
10.1016/J.TAAP.2013.06.016
P50
P577
2013-06-26T00:00:00Z